The Dow Jones Industrial Average (DJIA) completed a five-wave decline as predicted by the Elliott Wave Principle, bottoming on October 6 at 50,546. Since then, the index has been rallying, currently trading in the low 52,000s. Analysts suggest this rally could be a bounce before another dip, but if the October 6 low holds, the DJIA is likely to continue rising to new all-time highs around 57,000. A break below the October 6 low, however, could trigger a steep decline into the 40,000s.
The Dow Jones Industrial Average price forecast is the subject here, with Pluang market data providing context. For readers following US stocks, 110 out of 150 priced stocks rose while 40 fell. Notable movers include American Airlines Group Inc (AAL) at USD 12.17 with a +4.20% change, KeyCorp (KEY) at USD 20.72 with +4.02%, and AGNC Investment Corp (AGNC) at USD 8.78 with +3.97%. This data is as of Oct 21, 2026 01:51 WIB.
Moody's is expected to report Q3 2026 earnings of around $4.25 per share on revenue near $2.08 billion, driven by steady demand for credit ratings and growth in Moody's Analytics, especially from recurring subscriptions and AI tools. While Moody's In...
Raymond James increased its price target for Rapport Therapeutics to $86 following positive Phase 2 trial results of RAP-219, a drug treating acute bipolar mania. The trial showed statistically significant improvement in patients and a favorable safe...
Heartland Express reported a third-quarter 2026 revenue decline of 8.7% to $179.5 million, missing analyst estimates. Despite lower revenue, the company returned to profitability with a net income of $1.0 million, compared to a loss last year. The op...
Catholic Medical Mission Board (CMMB) held a ribbon-cutting ceremony for its new Distribution Center at the Brethren Service Center in New Windsor, Maryland. This move enhances CMMB's Access to Medicines Program by expanding operational capacity and ...
Piper Sandler upgraded Myriad Genetics from Underweight to Neutral and set a $5.00 price target after the company agreed to sell its prenatal health testing business to Labcorp for $210 million in cash. This sale includes several prenatal tests and i...
